rethinkPeptides Search
Menu
Study breakdown

Different Tissues Process the Opioid Precursor Prodynorphin Into Different Active Peptides

In VitroPreliminary evidence
The takeaway

A newly characterized processing enzyme produces different dynorphin peptides in different tissues, explaining why the opioid system has different effects throughout the body.

Tissue-specific products

Brain produces dynorphins A and B; peripheral tissues produce big dynorphin and leumorphin from the same precursor

What the researchers found

A prodynorphin processing enzyme was isolated and characterized, revealing tissue-specific processing that generates different bioactive dynorphin peptides in brain versus peripheral tissues like adrenal gland and gut.

Why it matters

Understanding why different tissues produce different opioid peptides from the same precursor helps explain why opioid signaling varies across body systems and could inform targeted opioid therapies.

How the study worked

In-vitro biochemistry study. The processing enzyme was isolated from various rat tissues using chromatography. Tissue distribution was mapped, and cleavage products were identified to characterize tissue-specific processing patterns.

What this study cannot tell us

In-vitro enzyme characterization in rat tissues. Processing patterns may differ in humans. The functional consequences of tissue-specific processing were not tested.

How to read the evidence

Preliminary evidence from in-vitro enzyme characterization providing novel insights into opioid peptide biosynthesis across tissues.

When this study was published

Published in 1999. Prodynorphin processing continues to be studied for its role in pain, addiction, and neuroendocrine regulation.

The bigger picture

The opioid system isn't uniform — the brain, gut, and other organs each have their own opioid peptide profiles. This tissue-specific processing adds another layer of complexity to pain, mood, and gut regulation by endogenous opioids.

Questions still open

  • Can tissue-specific processing be targeted to modulate opioid effects in specific organs?
  • Is altered processing involved in chronic pain conditions?
  • Do processing enzyme levels change with disease or aging?

Common questions

What is prodynorphin?
Prodynorphin is a precursor protein that the body cuts into multiple opioid peptides including dynorphin A, dynorphin B, and neo-endorphins. These peptides regulate pain, mood, and gut function.
Why does it matter that different tissues make different peptides?
It means the opioid system is tailored to each organ's needs. The brain gets one set of opioid signals for pain and mood, while the gut gets a different set for digestive regulation. This could enable organ-targeted opioid therapies.

Read the original research

Dynorphin A processing enzyme: tissue distribution, isolation, and characterization.

Journal of biochemistry, 125(3), 641-7

Citation

Berman, Y; Ageyeva, L; Veksler, B; Wood, D; Devi, L A. (1999). Dynorphin A processing enzyme: tissue distribution, isolation, and characterization.. Journal of biochemistry, 125(3), 641-7.